A 35-year-old male from Delhi with pulmonary TB on standard first-line therapy (HRZE) for 4 months shows persistent positive sputum smear microscopy and worsening radiological findings. Clinical suspicion for MDR-TB is high. Which investigation is the gold standard for confirming drug resistance and guiding second-line therapy?